Clinical trial

Adult Subjects With Uncontrolled Type 2 Diabetes

NCT02317796

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-12-01

PhasePHASE2

Study timeline

Study start (unknown)2014-12-01Date precision: month

Registry last updated2016-09-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

MLR-1023DRUG

Sponsors & collaborators

Melior Pharmaceuticalslead sponsor

Bukwang Pharmaceutical, Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02317796 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.